KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio: 2009-2025

Historic Interest Coverage Ratio for Regeneron Pharmaceuticals (REGN) over the last 15 years, with Sep 2025 value amounting to 53.20.

  • Regeneron Pharmaceuticals' Interest Coverage Ratio fell 37.75% to 53.20 in Q3 2025 from the same period last year, while for Sep 2025 it was 87.61, marking a year-over-year increase of 38.90%. This contributed to the annual value of 72.30 for FY2024, which is 30.40% up from last year.
  • As of Q3 2025, Regeneron Pharmaceuticals' Interest Coverage Ratio stood at 53.20, which was down 82.26% from 299.86 recorded in Q2 2025.
  • In the past 5 years, Regeneron Pharmaceuticals' Interest Coverage Ratio registered a high of 299.86 during Q2 2025, and its lowest value of 46.67 during Q1 2024.
  • Its 3-year average for Interest Coverage Ratio is 85.61, with a median of 62.42 in 2023.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Interest Coverage Ratio slumped by 64.80% in 2022 and then spiked by 314.92% in 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at 187.21 in 2021, then slumped by 64.80% to 65.91 in 2022, then decreased by 19.34% to 53.16 in 2023, then surged by 77.38% to 94.30 in 2024, then tumbled by 37.75% to 53.20 in 2025.
  • Its last three reported values are 53.20 in Q3 2025, 299.86 for Q2 2025, and 68.01 during Q1 2025.